The phenomenon of glycated hemoglobin in patients with a new coronavirus infection (COVID-19) with type 2 diabetes mellitus
Автор: Sklyarov Bogdan А., Samoilova Alena D., Pavlov Bogdan V., Levina Anastasia V., Sinelnikova Irina S., Vardanyan Susanna М., Papin Viktor А.
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 26, 2023 года.
Бесплатный доступ
During the pandemic of coronavirus infection, medical staff around the world has faced the problem of a significant deterioration in the health conditions of patients, who have a history of type 2 diabetes mellitus and who have infected with COVID-19.The problem of the combination of the coronavirus infection and diabetes mellitus is urgent and requires an indepth study in this context. This article presents and reviews some results of an experiment during which the clinical indicators of 15 patients with type 2 diabetes mellitus, with elevated glycated hemoglobin, infected with coronavirus infection, aged 45 to 65, were taken on the 14th day of observation.
Glycated hemoglobin, type 2 diabetes mellitus, coronavirus infection, blood glucose level, phenomenon
Короткий адрес: https://sciup.org/148326599
IDR: 148326599 | DOI: 10.18137/cardiometry.2023.26.139143
Список литературы The phenomenon of glycated hemoglobin in patients with a new coronavirus infection (COVID-19) with type 2 diabetes mellitus
- Guan WJ,Ni ZY,Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382:1708-20.
- Yang J, Zheng Y, Gou X, et al.: Prevalence of comorbidities and its effects in patients infected with SARSCoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020, 94:91-5. 10.1016/j.ijid.2020.03.017.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016/S0140-6736(20)30566-3.
- Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM, National Academy of Clinical Biochemistry. Evidence-Based Laboratory Medicine Committee of the American Association for clinical chemistry guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;6:e61–99.
- American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement 1): S15–33.
- American Diabetes Association. Glycemic targets: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S73–84.
- Means C. (2020). Mechanisms for increasing morbidity and mortality from SARS-CoV-2 infection in people with diabetes: what it means for an effective management strategy. Metabolism108, 154254.
- Khalbaginov AA, et al. Clinical and histological studies of the pathophysiological impact of COVID-19 on the cardiovascular system. International Journal of Medicine and Psychology. 2022;5(4):139-45. [in Russian]
- Voronin IМ, et al. Pathophysiological analysis of the impact of COVID-19 on the morphological characteristics of patients' organisms. International Journal of Medicine and Psychology. 2021;4(6):150-6. [in Russian]
- Misnikova IV, et al Glycated hemoglobin is the main parameter in the control of diabetes mellitus. Diabetes. 2008;4:38-40. [in Russian]
- Belikina DV, et al. COVID-19 in concomitant diabetes mellitus: features of the clinical course, metabolism, inflammatory and coagulation disorders. Modern technologies in medicine. 2020;12(5):6-18. [in Russian]
- Cherkasova YB, et al. The combination of type I diabetes mellitus and diabetes associated with a mutation in the GCK gene. Questions of history. 2022;8-2:280-7. [in Russian]
- Yulia B. Cherkasova, et al. Combination of type I diabetes mellitus and diabetes associated with GCK gene mutation: features of the clinical course in puberty. Cardiometry; Issue 24; November 2022; p.210-216; DOI: 10.18137/cardiometry.2022.24.210216;
- Ilyin AV, et al. Glycated hemoglobin as a key parameter in monitoring patients with diabetes mellitus. Optimal organization of research. Diabetes. 2008;2:60-4. [in Russian]
- Sklyarov BA. Research data and findings related to the omicron strain of coronavirus (COVID-19). International Journal of the Humanities and Natural Sciences. 2022;5-1(68):102-5. [in Russian]
- Biryukova EV. The role of glycated hemoglobin in the diagnosis and improvement of the prognosis of diabetes mellitus. Medical council. 2017;3:48-53. [in Russian]
- Majatsaria АD, et al. Coronavirus infection (COVID-19) and disseminated intravascular coagulation syndrome. Obstetrics, gynecology and reproduction. 2020;14(2):123-31. [in Russian]
- Shestakova MV, et al. Diabetes mellitus in the context of the COVID-19 viral pandemic: features of the course and treatment. Diabetes. 2020;23(2):132-9. [in Russian]
- Shestakova MV, et al. Diabetes mellitus and COVID-19: analysis of clinical outcomes according to the diabetes registry of the Russian Federation. Problems of endocrinology. 2020;66(1):35-46. [in Russian]
- Glybochko PV, et al. Outcomes in patients with severe COVID-19 hospitalized for respiratory support in intensive care units. Clinical pharmacology and therapy. 2020;29(3):25-36. [in Russian]
- Glybochko PV, et al. Clinical characteristics of 1007 patients with severe SARS-CoV-2 pneumonia requiring respiratory support. Clinical pharmacology and therapy. 2020;29(2):21-9. [in Russian]
